Global In Vitro Diagnostics (IVD) Quality Control Market to Reach $1.8 Billion by 2030
The global market for In Vitro Diagnostics (IVD) Quality Control estimated at US$1.3 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Clinical Chemistry Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$607.6 Million by the end of the analysis period. Growth in the Immunochemistry Application segment is estimated at 4.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $336 Million, While China is Forecast to Grow at 8.7% CAGR
The In Vitro Diagnostics (IVD) Quality Control market in the U.S. is estimated at US$336 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$437.6 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.1% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$262.4 Million by the year 2030.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook